Good evening :)
Place Order
Add to Watchlist
Home
Portfolio
Search
GoldGold
More

Indo Us Bio-Tech Ltd

INDOUS

Indo Us Bio-Tech Ltd

INDOUS
Consumer StaplesAgro Products
SmallcapWith a market cap of ₹501 cr, stock is ranked 1,819
High RiskStock is 4.60x as volatile as Nifty
251.101.80% (+4.45)
251.101.80% (+4.45)

Price Chart

High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Consumer StaplesAgro Products
SmallcapWith a market cap of ₹501 cr, stock is ranked 1,819
High RiskStock is 4.60x as volatile as Nifty

How to use scorecard? Learn more

Consumer StaplesAgro Products
SmallcapWith a market cap of ₹501 cr, stock is ranked 1,819
High RiskStock is 4.60x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
32.527.99—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
50.8710.101.48%

Forecast & Ratings

Detailed Forecast 
—
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Indo US Bio-Tech Ltd is a agriculture seed company that is into research and development, production, marketing and sales of all types of Agriculture Seeds.

Peers

Compare with peers 
Compare with Peers

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Price Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Revenue Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Earnings Per Share Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 15.64%, vs industry avg of 6.37%

Increasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.19% to 0.22%

Higher than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 31.6%, vs industry avg of 2.76%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue19.1524.5829.6235.3839.7740.1350.2361.7673.16107.30
Raw Materialssubtract17.7820.1224.1626.712.812.462.185.275.8888.62
Power & Fuel Costsubtract0.020.020.030.030.030.070.070.140.18
Employee Costsubtract0.380.360.380.270.350.340.481.190.92
Selling & Administrative Expensessubtract1.491.521.543.403.045.594.613.687.61
Operating & Other expensessubtract-1.131.240.571.5129.5726.1035.7742.0847.44
Depreciation/Amortizationsubtract0.140.150.170.250.230.260.440.830.800.96
Interest & Other Itemssubtract0.220.640.720.400.881.181.201.201.521.95
Taxes & Other Itemssubtract-0.120.130.590.720.33-0.970.250.150.560.35
EPS0.280.300.660.921.743.502.041.882.747.69
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.000.00
See Costs

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ cr

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2020

Annual report

PDF
FY 2021

Annual report

PDF
FY 2022

Annual report

PDF
FY 2023

Annual report

PDF
FY 2024

Annual report

PDF
 

Peers & Comparison

Comparing 3 stocks from 
Consumer StaplesAgro Products

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Indo Us Bio-Tech Ltd60.787.99—
Godrej Agrovet Ltd38.884.791.37%
Gujarat Ambuja Exports Ltd16.052.000.29%
Sanstar Ltd30.307.97—

Price Comparison

Compare INDOUS with any stock or ETF
Compare INDOUS with any stock or ETF
INDOUS
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding70.17%0.00%0.00%0.00%29.83%

Mar 2024

Jun 2024

Aug 2024

Sep 2024

Shareholding History

SepDec '23MarJunAugSep0.00%0.00%0.00%0.00%0.00%0.00%

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

INDOUS has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

Cash Dividend

Ex DateEx DateDec 3, 2024

Interim
Interim | Div/Share: ₹0.25

Dividend/Share

₹0.25

Ex DateEx Date

Dec 3, 2024

Past Dividends

Cash Dividend

Ex DateEx DateOct 28, 2021

Interim
Interim | Div/Share: ₹0.25

Dividend/Share

₹0.25

Ex DateEx Date

Oct 28, 2021

News & Opinions
Corporate
Indo Us Bio-Tech fixes record date for interim dividend

Indo Us Bio-Tech has fixed 03 December 2024 as record date for payment of interim dividend for FY 2024-25. The payment will be completed on or before 19 December 2024. Powered by Capital Market - Live

2 days agoCapital Market - Live
Corporate
Board of Indo US Bio-Tech recommends Interim Dividend

Indo US Bio-Tech announced that the Board of Directors of the Company at its meeting held on 21 November 2024, has recommended a Interim dividend of Rs.0.25 per share (i.e.2.5%), subject to the approval of the shareholders.Powered by Capital Market - Live

3 days agoCapital Market - Live
Earnings
Indo US Bio-Tech standalone net profit rises 161.08% in the September 2024 quarter

Net profit of Indo US Bio-Tech rose 161.08% to Rs 4.36 crore in the quarter ended September 2024 as against Rs 1.67 crore during the previous quarter ended September 2023. Sales rose 40.23% to Rs 22.17 crore in the quarter ended September 2024 as against Rs 15.81 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales22.1715.81 40 OPM %23.1416.45 - PBDT4.632.19 111 PBT4.451.98 125 NP4.361.67 161 Powered by Capital Market - Live

1 week agoCapital Market - Live
Corporate
Indo US Bio-Tech revises board meeting date

Indo US Bio-Tech has revised the meeting of the Board of Directors which was scheduled to be held on 16 November 2024. The meeting will now be held on 21 November 2024.Powered by Capital Market - Live

1 week agoCapital Market - Live
Corporate
Indo US Bio-Tech to consider Interim Dividend

Indo US Bio-Tech will hold a meeting of the Board of Directors of the Company on 16 November 2024Powered by Capital Market - Live

1 week agoCapital Market - Live
Corporate
Indo US Bio-Tech announces board meeting date

Indo US Bio-Tech will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live

2 weeks agoCapital Market - Live
Corporate
Indo US Bio-Tech to conduct AGM

Indo US Bio-Tech announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live

2 months agoCapital Market - Live
Earnings
Indo US Bio-Tech standalone net profit rises 33.76% in the June 2024 quarter

Net profit of Indo US Bio-Tech rose 33.76% to Rs 3.17 crore in the quarter ended June 2024 as against Rs 2.37 crore during the previous quarter ended June 2023. Sales rose 29.15% to Rs 24.72 crore in the quarter ended June 2024 as against Rs 19.14 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales24.7219.14 29 OPM %14.9315.62 - PBDT3.392.65 28 PBT3.192.45 30 NP3.172.37 34 Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Indo US Bio-Tech to announce Quarterly Result

Indo US Bio-Tech will hold a meeting of the Board of Directors of the Company on 8 August 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live